2-[2-(6-BroMohexyloxy)ethoxyMethyl]-1,3-dichlorobenzene

2-[2-(6-Bromohexyloxy)ethoxymethyl]-1,3-dichlorobenzene (CAS 503070-57-3) is identified by the supplier, Hunan HuaTeng Pharmaceutical Co., Ltd., as a Vilanterol intermediate — Vilanterol being the ultra-long-acting beta2 adrenoreceptor agonist marketed as Breo Ellipta in combination with fluticasone furoate for COPD. The compound is offered in pharmaceutical grade, though not directly manufactured, with distribution to North America, Western and Eastern Europe, and Asia.